CARLSBAD, Calif., May 26, 2021 /PRNewswire/ -- Ionis
Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that
management will present a company overview at the following virtual
investor conferences:
- William Blair 41st
Annual Growth Stock Conference on Tuesday,
June 1, 2021
- Goldman Sachs 42nd Annual Global Healthcare
Conference on Wednesday, June 9,
2021
- Nasdaq 44th Investor Conference on Tuesday, June 15, 2021
- BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology
on Tuesday, June 22, 2021
The above listed dates are subject to change. Details on
presentation times or changes to presentation dates can be found on
the Company's website. Please check www.ionispharma.com for the
latest information.
A live webcast of the presentations will be available on the
Investors & Media section of the Ionis website. The replays
will be available within 48 hours and will be archived for a
limited time.
About Ionis Pharmaceuticals
For more than 30 years,
Ionis has been the leader in RNA-targeted therapy, pioneering new
markets and changing standards of care with its novel antisense
technology. Ionis currently has three marketed medicines and a
premier late-stage pipeline highlighted by industry-leading
neurological and cardiometabolic franchises. Our scientific
innovation began and continues with the knowledge that sick people
depend on us, which fuels our vision of becoming one of the most
successful biotechnology companies.
To learn more about Ionis visit www.ionispharma.com and
follow us on Twitter @ionispharma.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301299234.html
SOURCE Ionis Pharmaceuticals, Inc.